Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

US-based Sagent Pharma Raises $40 Million from China

publication date: Apr 12, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sagent Pharmaceuticals of Schaumberg, Illinois raised $40 million in two tranches of a series B financing from China sources. Zhejiang Hisun Pharmaceutical invested $10 million, which we reported earlier, and the remaining $30 million was contributed by an unnamed China-focused private equity investment fund. Sagent is building a large portfolio of generic injectable products that are “high quality, low cost,” using a global network of partners. More details...

Stock Symbol: (SHA: 600267)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners